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Small Vessel Disease and General Cognitive Function in
Nondisabled Elderly
The LADIS Study
Wiesje M. van der Flier, PhD; Elizabeth C.W. van Straaten, MD; Frederik Barkhof, MD, PhD;
Ana Verdelho, MD; Sofia Madureira, PsyP; Leonardo Pantoni, MD, PhD; Domenico Inzitari, MD;
Timo Erkinjuntti, MD, PhD; Militta Crisby, MD, PhD; Gunhild Waldemar, MD, DMSc;
Reinhold Schmidt, MD; Franz Fazekas, MD; Philip Scheltens, MD, PhD;
on behalf of the LADIS Study Group
Background and Purpose—On cerebral magnetic resonance imaging (MRI), white matter hyperintensities (WMH) and
lacunes are generally viewed as evidence of small vessel disease. The clinical significance of small vessel disease in
terms of global cognitive function has as yet not been completely clarified. We investigated the independent contribution
of WMH and lacunes to general cognitive function in a group of independently living elderly with varying degrees of
small vessel disease.
Methods—Data were drawn from the multicenter, multinational Leukokraurosis and Disability (LADIS) study. There were
633 independently living participants. General cognitive function was assessed using the Mini Mental State Examination
(MMSE) and the modified Alzheimer Disease Assessment Scale (ADAS). On MRI, WMH was rated as mild, moderate,
or severe. Lacunes were rated as none, few (1 to 3), or many (4 or more).
Results—In the basic analysis, increasing severity of both WMH and lacunes was related to deteriorating score on the
MMSE and ADAS. When WMH and lacunes were entered simultaneously, both MRI measures remained significantly
associated with MMSE score. Increasing severity of WMH remained associated with ADAS score, whereas the
association with lacunes became less prominent. These associations were independent of other risk factors for dementia,
like education, depression, vascular risk factors, or stroke.
Conclusion—We found WMH and lacunes to be independently associated with general cognitive function in a sample of
independently living elderly. These results highlight the fact that WMH and lacunes should both be evaluated when
assessing small vessel disease in relation to cognitive function. (Stroke. 2005;36:2116-2120.)
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Cerebrovascular disease encompasses both (large vessel)cortical ischemic and hemorrhagic infarcts and subcor-
tical small vessel disease. Although it is generally accepted
that cortical stroke may cause cognitive impairment, the
clinical significance of small vessel disease in terms of global
cognitive function has as yet not been completely clarified.
On cerebral magnetic resonance imaging (MRI), white matter
hyperintensities (WMH) and lacunes, both of which are
frequently observed in the elderly, are generally viewed as
evidence of small vessel disease.1–4 Associations with vascu-
lar risk factors have been shown for both WMH and lacunes,
providing circumstantial support for the view that these MRI
abnormalities reflect small vessel disease.5–10
There is increasing attention for the importance of small
vessel disease as a predictor of cognitive decline and dementia.
Small vessel disease is implicated in vascular dementia.11,12
Moreover, it seems to amplify the effects of pathologic changes
of Alzheimer disease.13–15 Subtle associations between WMH
and cognitive impairment have been reported in nondemented
elderly.5,16,17 The cognitive correlates of lacunes have received
less attention. Results are conflicting, because some authors
report associations with cognitive impairment, whereas others
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do not.9,18,19 In addition, the relative impact of WMH and
lacunes on cognitive impairment is not known.
In the present study, we investigated the independent
contribution of WMH and lacunes to general cognitive
function in a group of independently living elderly with
varying degrees of small vessel disease.
Materials and Methods
Data were drawn from the multicenter, multinational Leukoaraiosis
and Disability (LADIS) study. The LADIS project prospectively
studies the role of WMH as an independent predictor of the transition
to disability in nondisabled elderly.20 In short, 639 elderly subjects,
who had no or only mild disability in their instrumental activities of
daily living (IADLs), and were stratified for grade of WMH severity,
were enrolled. Subjects presented for evaluation in the following
settings: stroke units or stroke departments, cerebrovascular disease
clinics, memory or dementia clinics, neurologic or geriatric wards/
clinics, population studies on aging, and controls in other studies.
Among the reasons for presentation were mild memory loss, minor
motor disturbances, minor focal cerebrovascular events, or nonspe-
cific reasons for undergoing a cranial neuroimaging study (WMH as
incidental finding). To be included, subjects had to have: (1) age
between 65 and 84 years; (2) WMH on MRI of any degree,
according to the categorization into the 3 severity classes of the
Fazekas scale,21 (3) no or only mild disability as determined by the
IADL scale22; (4) presence of a regularly contactable informant; and
(5) agreement to sign an informed consent. Exclusion criteria were:
(1) likely dropout because of the presence of severe illnesses
(cardiac, hepatic, or renal failure, cancer or other relevant systemic
diseases), (2) severe unrelated neurologic diseases, (3) leukoenceph-
alopathy of nonvascular origin (immunologic–demyelinating, meta-
bolic, toxic, infectious, other), (4) severe psychiatric disorders, (5)
inability to give informed consent, and (6) inability or refusal to
undergo cerebral MRI. Subjects are currently followed up for 3 years
with repeated clinical and MRI studies. The present article is based
on the baseline data of the LADIS project.
All subjects were assessed using clinical and functional tests,
including global functioning, cognitive, motor, psychiatric, and
quality-of-life measures. For the present study, general cognitive
function was measured using the Mini Mental State Examination
(MMSE)23 and a modified version of the Alzheimer Disease Assess-
ment Scale (ADAS).24 The ADAS was slightly modified to include
the item “delayed word recall.” A higher MMSE score indicates
better performance, whereas a higher ADAS score corresponds to
worse performance. ADAS score was missing in 6 subjects, so 633
subjects had available data for the present study. The following
variables were evaluated as confounders: age, sex, education (years),
depressive symptoms,25 motor function,26,27 hypertension, diabetes,
smoking, and history of stroke.
All subjects were studied by MRI following a standard protocol on
the same day as the clinical investigation. Scans were made on a
0.5-T (one center) or 1.5-T scanner (10 centers) and were collected
centrally at the Image Analysis Centre (IAC) of the Vrije Universiteit
Medical Center, Amsterdam. Imaging guidelines were distributed
among all centers, specifying naming convention and scan position-
ing. To check and maintain quality, dummy runs were requested
before the beginning of the study and in case of upgrades. Data
transfer was electronic through FTP. The MR protocol included the
following sequences: T1-weighted 3D MPRAGE (magnetization
prepared rapid-acquisition gradient-echo, scan parameters: coronal
or sagittal plane, field of view [FOV] 250 mm, matrix 256256 or
512512, slice thickness: 1 mm [isotropic voxels], TE: 2 to 7 ms,
TR: 9 to 26 ms, FA 10% to 30%), T2-weighted FSE (fast spin echo,
scan parameters: axial plane, FOV 250 mm, matrix 256256 or
512512, slice thickness: 5 mm, interslice gap 0.5 mm, TE: 100 to
130 ms, TR: 4000 to 8000 ms), and FLAIR (fluid-attenuated
inversion recovery, scan parameters: axial plane, FOV 250 mm,
matrix 256256 or 512512, slice thickness: 5 mm, interslice gap
0.5 mm, TE: 100 to 160 ms, TR: 6000 to 10000 ms, TI: 2000 to
2400). Visual ratings of WMH and counts of lacunes were performed
centrally by a single rater (ECWvS) who was blind to clinical details.
The degree of WMH severity was rated visually on axial FLAIR
images using the Fazekas scale as grade 1 (punctate), grade 2 (early
confluent), or grade 3 (confluent).21 Lacunes were defined as
hypointense foci of 3 mm on MPRAGE that were surrounded by
white matter or subcortical gray matter and not located in areas with
a high prevalence of widened perivascular spaces (eg, anterior
commissure, vertex).28 The number of lacunes was recoded into
none, few (1 to 3 lacunes), and many (4 lacunes or more). The
intrarater reliability of rating of WMH was determined on 18
randomly selected scans that were scored twice (weighted Cohen
0.84). Interrater reliabilities and intrarater reliability of lacunes
were not determined.
Statistical analysis was performed using SPSS for windows
(release 11.5). Spearman’s correlation was used to assess the
association between WMH and lacunes. The strength of the associ-
ations between small vessel disease and cognitive measures was
assessed using partial correlations, correcting for age and sex.
Associations between small vessel disease and general cognitive
function were assessed using general linear models for MMSE and
ADAS separately. WMH and lacunes were entered as continuous
variables. Age and sex were entered as covariates in all models. First,
basic associations between general cognitive function and WMH and
between general cognitive function and lacunes were assessed.
Subsequently, WMH and lacunes were entered simultaneously to
assess their independent contribution to cognitive function. The
interaction between WMH and lacunes was tested. Because 11
different centers participate in the LADIS project, it is conceivable
that center of origin acts as a confounder in the association between
small vessel disease and cognition. Therefore, center of origin was
entered as a factor in the GLM. Additional corrections were made for
education, depressive symptoms, motor function, hypertension, dia-
betes, smoking, and a history of stroke.
Results
Characteristics of the participants are presented in Table 1.
The number of lacunes increased with the severity of WMH
(Spearman r0.25, P0.001; Figure 1).
General linear models were performed for WMH and
lacunes separately, correcting for age and sex and with the
MMSE and the ADAS as dependent variable. In these basic
models, WMH and lacunes each were associated with score
on the MMSE and ADAS (MMSE-WMH: [se]0.48
[0.12], P0.001; MMSE-lacunes: [se]0.62 [0.14]),
TABLE 1. Baseline Characteristics of Subjects in the
LADIS Study (n633)
Age (y) 74 (5)
Women 350 (55%)
Education (y) 10 (4)
Mini Mental State Examination 27 (2)
Alzheimer Disease Assessment Scale (ADAS)* 17 (7)
White matter hyperintensities
Mild 282 (44%)
Moderate 195 (31%)
Severe 156 (25%)
Lacunes
None (0) 332 (52%)
Few (1 to 3) 218 (35%)
Many (4) 83 (13%)
Values are means (standard deviation) or numbers (percentages).
*The ADAS was slightly modified to include the item “delayed word recall.”
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P0.001, ADAS-WMH: [se]1.31 [0.35], P0.001;
ADAS-lacunes: [se]1.12 [0.41], P0.007, Figure 2). Par-
tial correlations corrected for age and sex were 0.16 and
0.18 (both P0.001) for MMSE with WMH and lacunes,
respectively, and 0.15 (P0.001) and 0.11 (P0.007) for
ADAS with WMH and lacunes.
To assess the independent effect of WMH and lacunes on
general cognitive function, both variables were entered si-
multaneously into general linear models (Table 2). Increasing
WMH and lacunes were independently associated with a
lower score on the MMSE. With increasing severity of
WMH, the performance on the ADAS deteriorated. In the
multivariate model, increasing severity of lacunes tended to
be associated with worse performance on the ADAS, but this
association was less prominent. There was no interaction
between lacunes and WMH. The interaction term was there-
fore left out of subsequent analyses. Correction for possible
confounders left results largely unaltered. Results did not
change after exclusion of subjects with an infarct other than
a lacune on MRI.
Discussion
The main finding of the current study is that WMH and
lacunes are independently associated with general cognitive
function in a large sample of nondisabled elderly subjects.
Small vessel disease is prevalent among the elderly.29,30
Several population-based studies have shown before that,
small vessel disease may cause subtle cognitive deficits in
nondemented subjects.5,9,16,17 In the present study, we dem-
onstrated that both WMH and lacunes independently influ-
ence cognitive function. We found only a moderate correla-
tion between WMH and lacunes, supporting the view that
they are 2 distinct expressions of small vessel disease.
Lacunar infarcts are produced when the ischemic damage is
focal and of sufficient severity to result in a small area of
necrosis.12 They are largely confined to the cerebral white
matter and subcortical structures, including the basal ganglia,
thalamus, and brain stem. In contrast, diffuse WMH, consid-
ered to be a form of rarefaction or incomplete infarction, are
usually widespread.
In the present study, we defined small vessel disease as
WMH and lacunes on MRI. Although these MRI abnormal-
ities are generally considered as measures of small vessel
disease, they have in fact variable pathologic correlates.1–3,31
Arteriolosclerosis has been reported to be the primary factor
in the pathogenesis of WMH in the elderly. Alternatively,
WMH may have as diverse pathologic correlates as loss of
myelin, axons, and oligodendroglial cells, dilatation of
perivascular spaces, and mild reactive astrocytic gliosis.
There have been a few studies evaluating the simultaneous
effect of WMH and lacunes in a sample of subjects with a
broad range of cognitive impairment.19,32,33 In these studies,
WMH were found to be related to cognitive impairment, but
there were no independent associations between lacunes and
cognitive dysfunction. In addition, there has been a large
population-based study assessing risk factors and functional
consequence of lacunes that showed associations between
lacunes and cognitive function, even after correction for
WMH.9 In the present study, we demonstrated both lacunes
and WMH to be associated with general cognitive function as
measured using the MMSE. Scores on the ADAS were
related to WMH and lacunes in the basic analysis. However,
the association between ADAS score and lacunes was not
independent of WMH, although associations remained bor-
derline significant. Insufficient power may be partly respon-
sible for the disappearance of the significant association,
because the variability in ADAS is larger than the variability
in MMSE. Furthermore, ADAS and MMSE are both widely
used tests of general cognitive function. The fact that even
with these relatively crude measures, clear associations with
Figure 1. The number of lacunes increases with the extent of
white matter hyperintensities (Spearman r0.25, P0.001).
Figure 2. Bars represent estimated means (corrected for age and
sex) with estimated standard errors. After correction for age and sex,
general linear models revealed significant associations between white
matter hyperintensities (WMH) and Mini Mental State Examination
(MMSE) and modified Alzheimer Disease Assessment Scale (ADAS),
and between lacunes and MMSE and ADAS.
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small vessel disease were observed, underlines the clinical
relevance of both WMH and lacunes. However, it is conceiv-
able that tests of cognitive functions specifically associated
with small vessel disease such as mental speed and executive
function may yield even stronger associations with WMH and
lacunes.
Among the strengths of the present study is the large
sample size. Each subject underwent MRI scanning. All scans
were analyzed centrally, which guaranteed reliability of MRI
measures. Patients were selected to represent a broad range of
WMH, enabling us to assess the subtle associations of small
vessel disease and cognitive function. Among the limitations
of the study may be the subject selection. Subjects were
identified mainly in a hospital or secondary/tertiary referral
setting. The study sample was selected to represent the full
range of severity of WMH. Although stratification by WMH
may hamper the generalizability of the results to the general
population, the reasons for referral were those commonly
leading to discover WMH in elderly persons, so that the
LADIS sample likely reflects the assorted patient population
with WMH encountered in everyday clinical practice. Be-
cause subjects were selected to be nondisabled, we were not
able to evaluate the full spectrum of cognitive impairment.
Subjects were allowed to have minor problems such as mild
memory loss or minor motor disturbances. However, because
subjects were required to be nondisabled, subjects with
fullfledged dementia were not eligible. Consequently, we
may even have underestimated the strength of the associa-
tions between small vessel disease and cognitive function.
Another limitation is the fact that we did not include a
measure of cerebral gray matter volume. Therefore, it is
conceivable that the reported associations are the result of
global or regional atrophy rather than ischemic changes. The
cross-sectional setting of the present study prevents infer-
ences on the causality of the reported associations. Further
research is currently being performed to determine the con-
tribution of small vessel disease to cognitive decline over
time.
In conclusion, we found WMH and lacunes to be indepen-
dently associated with cognitive function in a sample of
independently living elderly. These results provide further
evidence for the importance of small vessel disease in
cognitive impairment at old age, and they highlight the fact
that WMH and lacunes should both be evaluated when
assessing small vessel disease in relation to cognitive
function.
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List of Participating Centers and Personnel
Helsinki, Finland (Memory Research Unit, Department of Clinical
Neurosciences, Helsinki University): Timo Erkinjuntti, MD, PhD,
Tarja Pohjasvaara, MD, PhD, Pia Pihanen, MD, Raija Ylikoski, PhD,
Hanna Jokinen, LPsych, Meija-Marjut Somerkoski, Mpsych, Riitta
Ma¨ntyla¨, MD, PhD; Graz, Austria (Department of Neurology and
MRI Institute, Medical University): Franz Fazekas, MD, Reinhold
Schmidt, MD, Stefan Ropele, PhD, Alexandra Seewann, MD, Katja
Petrovic, MagPsychol, Ulrike Garmehi; Lisboa, Portugal (Servic¸o de
Neurologia, Centro de Estudos Egas Moniz, Hospital de Santa
Maria): Jose´ M. Ferro, MD, PhD, Ana Verdelho, MD, Sofia
Madureira, PsyD; Amsterdam, The Netherlands (Department of
Neurology, VU Medical Center): Philip Scheltens, MD, PhD, Ilse
van Straaten, MD, Wiesje van der Flier, PhD, Alida Gouw, MD,
Frederik Barkhof, MD, PhD; Goteborg, Sweden (Institute of Clinical
Neuroscience, Goteborg University): Anders Wallin, MD, PhD,
Michael Jonsson, MD, Karin Lind, MD, Arto Nordlund, PsyD,
Sindre Rolstad, PsyD, Kerstin Gustavsson, RN; Huddinge, Sweden
(Neurotec Department, Section of Clinical Geriatrics, Karolinska
Universitetssjukhuset): Lars-Olof Wahlund, MD, PhD, Militta
Crisby, MD, PhD, Anna Pettersson, physiotherapist, Kaarina Am-
berla, PsyD; Paris, France (Department of Neurology, Hopital
Lariboisiere): Hugues Chabriat, MD, PhD, Ludovic Benoit, MD,
Karen Hernandez, Solene Pointeau, Annie Kurtz, Daniel Reizine,
MD; Mannheim, Germany (Department of Neurology, University of
Heidelberg, Klinikum Mannheim): Michael Hennerici, MD, Chris-
tian Blahak, MD, Hansjorg Baezner, MD, Martin Wiarda, PsyD,
Susanne Seip, RN; Copenhagen, Denmark (Copenhagen University
Hospital: Memory Disorders Research Unit, Department of Neurol-
ogy, Rigshopitalet, and the Danish Magnetic Resonance Research
Center, Hvidovre Hospital): Gunhild Waldemar, MD, DMSc, Egill
Rostrup, MD, MSc, Charlotte Ryberg, Tim Dyrby; Newcastle-upon-
Tyne, U.K. (Institute for Ageing and Health, University of New-
castle): John O’Brien, DM, Sanjeet Pakrasi, MRCPsych, Thais
TABLE 2. Multivariate Associations Between Small Vessel Disease and Cognitive Function
Variables Adjusted for
MMSE ADAS
WMH Lacunes WMH Lacunes
Age, sex 0.36 (0.12)† 0.51 (0.14)† 1.13 (0.37)† 0.78 (0.42)§
Age, sex, center of origin* 0.40 (0.13)† 0.50 (0.14)† 1.17 (0.35)† 0.61 (0.40)
Age, sex, education 0.34 (0.12)† 0.33 (0.14)‡ 1.08 (0.35)† 0.35 (0.41)
Age, sex, depressive symptoms 0.31 (0.12)‡ 0.47 (0.14)† 1.00 (0.37)† 0.68 (0.42)
Age, sex, motor function 0.21 (0.13)§ 0.44 (0.14)† 0.87 (0.38)‡ 0.67 (0.43)
Age, sex, hypertension, diabetes, smoking 0.30 (0.12)‡ 0.51 (0.14)† 1.09 (0.37)† 0.73 (0.42)§
Age, sex, history of stroke 0.38 (0.13)† 0.52 (0.14)† 1.20 (0.38)† 0.83 (0.43)§
Values are betas and their standard errors. Betas represent the increase in test score with one-level increase of
WMH or lacune. Models have MMSE or ADAS as the dependent variable and both WMH and lacunes as independent
variables. Therefore, the reported associations of WMH are conditional on lacunes and vice versa. In addition, other
potentially confounding variables were entered into the model. The number of missing values varied but was less than
2% of the total number of participants in a particular model.
*Because 11 different centers participate in the LADIS project, center of origin may act as a confounder. Therefore,
center of origin was entered as a factor in the GLM.
†P0.01, ‡P0.05, §P0.10.
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Coordinator); Leonardo Pantoni, MD, PhD, Anna Maria Basile, MD,
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Luciano Bartolini, PhD, Emilia Salvadori, PhD, Marco Moretti, MD,
Mario Mascalchi, MD, PhD.
The LADIS Steering Committee is formed by Domenico Inzitari,
MD (study coordinator), Timo Erkinjuntti, MD, PhD, Philip Schel-
tens, MD, PhD, Marieke Visser, MD, PhD, and Kjell Asplund, MD,
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